ARMC4 Activators are a collection of chemical compounds that facilitate the functional activity of ARMC4 through the modulation of specific signaling pathways, mainly involving the elevation of cAMP levels and subsequent activation of PKA, which plays a crucial role in ciliary functions. Forskolin, a well-known adenylyl cyclase activator, indirectly enhances ARMC4 activity by increasing intracellular cAMP levels, leading to the activation of PKA. This cascade of events promotes the phosphorylation of substrates involved in ciliary processes, a domain where ARMC4 is essential. Similarly, compounds such as Vinpocetine and IBMX, which inhibit phosphodiesterases, contribute to the elevation of cAMP levels, thus indirectly promoting ARMC4 activity via PKA activation. This is crucial for the regulation of ciliary motility and assembly, processes integral to ARMC4's functional role. Other compounds like Rolipram and Cilostamide, selective inhibitors of PDE4 and PDE3 respectively, also enhance cAMP levels, further facilitating PKA activation and indirectly supporting ARMC4's role in ciliary processes.
The activation of ARMC4 through these pharmacological agents is further augmented by compounds like Dibutyryl-cAMP, Milrinone, and Anagrelide. Dibutyryl-cAMP, a cAMP analog, directly increases cAMP levels, leading to enhanced PKA activity, thereby indirectly supporting ARMC4's involvement in ciliary function. Milrinone and Anagrelide, both PDE3 inhibitors, elevate cAMP levels and thereby activate PKA, which is crucial for ARMC4's functional involvement in ciliary motility and assembly. Pentoxyfylline, Zardaverine, Trequinsin, and Siguazodan, also contribute to this pharmacological profile by inhibiting phosphodiesterases, leading to increased cAMP and subsequently activated PKA. This consistent activation of PKA, central to ARMC4's role, underscores the significance of these chemical activators in enhancing the functional activity of ARMC4, particularly in the context of ciliary processes, crucial for its biological role.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin, by elevating cAMP levels, indirectly activates ARMC4. Elevated cAMP activates PKA, which can phosphorylate substrates involved in ciliary function, a key process where ARMC4 plays a crucial role. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine enhances phosphodiesterase (PDE) inhibition, leading to increased cAMP levels. This cascade indirectly activates ARMC4 by promoting ciliary processes through PKA activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a nonspecific inhibitor of phosphodiesterases, causing an increase in intracellular cAMP and subsequent activation of PKA. This indirectly enhances ARMC4's function in ciliary processes. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram, a selective PDE4 inhibitor, raises cAMP levels, thereby activating PKA. PKA positively influences ciliary functions where ARMC4 is significantly involved. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $90.00 $350.00 | 16 | |
Cilostamide, a PDE3 inhibitor, increases intracellular cAMP, leading to PKA activation. This activation enhances ARMC4's role in ciliary motility and assembly. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, directly elevates cAMP levels, leading to PKA activation. This, in turn, promotes ARMC4's function in ciliary processes. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $162.00 $683.00 | 7 | |
Milrinone, a PDE3 inhibitor, boosts cAMP levels, which leads to PKA activation. PKA activation indirectly enhances ARMC4 function in ciliary motility. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $147.00 | ||
Anagrelide, another PDE3 inhibitor, increases cAMP levels, thereby activating PKA. Enhanced PKA activity supports ARMC4's role in ciliary processes. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Pentoxifylline, a phosphodiesterase inhibitor, raises cAMP levels, indirectly enhancing ARMC4's functional role in ciliary activity via PKA activation. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine, a dual PDE3/4 inhibitor, elevates cAMP levels, indirectly activating ARMC4 through enhanced PKA signaling, crucial for ciliary function. |